Chemokines and chemokine receptors: A new strategy for breast cancer therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemokines and chemokine receptors: A new strategy for breast cancer therapy
Authors
Keywords
-
Journal
Cancer Medicine
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-07
DOI
10.1002/cam4.3014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
- (2019) Andrea Walens et al. eLife
- Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop
- (2019) Ke Xu et al. MOLECULAR THERAPY
- Long Noncoding RNA-Maternally Expressed Gene 3 Contributes to Hypoxic Pulmonary Hypertension
- (2019) Yan Xing et al. MOLECULAR THERAPY
- CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2
- (2018) Han Xu et al. CANCER LETTERS
- PAI-1 induces Src inhibitor resistance via CCL5 in HER2-positive breast cancer cells
- (2018) Hehui Fang et al. CANCER SCIENCE
- LYG-202 inhibits activation of endothelial cells and angiogenesis through CXCL12/CXCR7 pathway in breast cancer
- (2018) Kai Zhao et al. CARCINOGENESIS
- Chemokines and cancer: new immune checkpoints for cancer therapy
- (2018) Nathan Karin CURRENT OPINION IN IMMUNOLOGY
- Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial
- (2018) Sonia Pernas et al. LANCET ONCOLOGY
- RNA Aptamers Recognizing Murine CCL17 Inhibit T Cell Chemotaxis and Reduce Contact Hypersensitivity In Vivo
- (2018) Lorenz Fülle et al. MOLECULAR THERAPY
- Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
- (2018) Lina Liu et al. MOLECULAR THERAPY
- miR-23b Suppresses Leukocyte Migration and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting CCL7
- (2018) Yuan Zhang et al. MOLECULAR THERAPY
- Atorvastatin Inhibits the HIF1α-PPAR Axis, Which Is Essential for Maintaining the Function of Human Induced Pluripotent Stem Cells
- (2018) Yoshiki Nakashima et al. MOLECULAR THERAPY
- Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling
- (2018) Rui Han et al. Scientific Reports
- The Atypical Chemokine Receptor Ackr2 Constrains NK Cell Migratory Activity and Promotes Metastasis
- (2018) Christopher A. H. Hansell et al. JOURNAL OF IMMUNOLOGY
- Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment
- (2018) J. M. Houthuijzen et al. CANCER AND METASTASIS REVIEWS
- CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells Through SRC and PKC Activation
- (2018) Min Yao et al. MOLECULAR CANCER RESEARCH
- CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer
- (2018) Asim Pervaiz et al. CELLULAR ONCOLOGY
- Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms
- (2017) Gage Brummer et al. MOLECULAR CANCER RESEARCH
- Incidence and Mortality and Epidemiology of Breast Cancer in the World
- (2016) Mahshid Ghoncheh et al. Asian Pacific Journal of Cancer Prevention
- Higher circulating levels of chemokine CXCL10 in patients with breast cancer: Evaluation of the influences of tumor stage and chemokine gene polymorphism
- (2016) A. Jafarzadeh et al. Cancer Biomarkers
- The CXCL8-CXCR1/2 pathways in cancer
- (2016) Qian Liu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Atypical chemokine receptors in cancer: friends or foes?
- (2016) Matteo Massara et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts
- (2016) B. Behnam Azad et al. JOURNAL OF NUCLEAR MEDICINE
- Macrophages: Regulators of the Inflammatory Microenvironment during Mammary Gland Development and Breast Cancer
- (2016) Nicholas J. Brady et al. MEDIATORS OF INFLAMMATION
- Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis
- (2016) P F Yu et al. ONCOGENE
- CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells
- (2016) Darrin Gao et al. Open Biology
- CXCL9: evidence and contradictions for its role in tumor progression
- (2016) Qiang Ding et al. Cancer Medicine
- CCL5-Mediated Th2 Immune Polarization Promotes Metastasis in Luminal Breast Cancer
- (2015) Q. Zhang et al. CANCER RESEARCH
- CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property
- (2015) Kenji Yamada et al. INTERNATIONAL JOURNAL OF CANCER
- CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
- (2015) Takanori Kitamura et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus
- (2015) A. J. Steiman et al. JOURNAL OF RHEUMATOLOGY
- Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer
- (2015) Ayesha Khalid et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration
- (2015) Timothy J. Zumwalt et al. Oncotarget
- CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer
- (2015) Ling Lin et al. Oncotarget
- Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer
- (2015) Heiyoun Jung et al. Journal for ImmunoTherapy of Cancer
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer
- (2014) Q Yang et al. BRITISH JOURNAL OF CANCER
- CXCL3 is a Potential Target for Breast Cancer Metastasis
- (2014) Amanda See et al. CURRENT CANCER DRUG TARGETS
- Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
- (2014) Naofumi Mukaida et al. MEDIATORS OF INFLAMMATION
- The Inflammatory Chemokine CCL5 and Cancer Progression
- (2014) Donatella Aldinucci et al. MEDIATORS OF INFLAMMATION
- Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
- (2014) Laura Bonapace et al. NATURE
- Chemokines in Cancer
- (2014) M. T. Chow et al. Cancer Immunology Research
- CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis
- (2013) Subir Biswas et al. BREAST CANCER RESEARCH AND TREATMENT
- CX3CL1 Promotes Breast Cancer via Transactivation of the EGF Pathway
- (2013) M. Tardaguila et al. CANCER RESEARCH
- Targeting CXCR2 Enhances Chemotherapeutic Response, Inhibits Mammary Tumor Growth, Angiogenesis, and Lung Metastasis
- (2013) B. Sharma et al. MOLECULAR CANCER THERAPEUTICS
- The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo
- (2013) Xiaoyang Ling et al. PLoS One
- Expression of CXCL14 and its anticancer role in breast cancer
- (2012) Xiao-Li Gu et al. BREAST CANCER RESEARCH AND TREATMENT
- CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells
- (2012) A. Tsuyada et al. CANCER RESEARCH
- Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
- (2012) G. Erdag et al. CANCER RESEARCH
- Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia
- (2012) Sensen Lin et al. CANCER SCIENCE
- A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells
- (2012) Yan Zhang et al. CELL RESEARCH
- Chemokine 25–induced signaling suppresses colon cancer invasion and metastasis
- (2012) Huanhuan Joyce Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Deficiency of C-C Chemokine Receptor 5 Suppresses Tumor Development via Inactivation of NF-κB and Upregulation of IL-1Ra in Melanoma Model
- (2012) Ju Kyoung Song et al. PLoS One
- CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3
- (2011) Jingqi Chen et al. CANCER CELL
- Plasma Biomarker Profiles Differ Depending on Breast Cancer Subtype but RANTES Is Consistently Increased
- (2011) R. M. Gonzalez et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Chemokine receptor CXCR4-mediated transformation of mammary epithelial cells by enhancing multiple RTKs expression and deregulation of the p53/MDM2 axis
- (2011) Hua Su et al. CANCER LETTERS
- Mesenchymal stem cells promote mammary cancer cell migration in vitro via the CXCR2 receptor
- (2011) Jennifer L. Halpern et al. CANCER LETTERS
- CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization
- (2011) S. Liekens et al. CURRENT PHARMACEUTICAL DESIGN
- Atypical chemokine receptors
- (2011) Maria Helena Ulvmar et al. EXPERIMENTAL CELL RESEARCH
- Differential Estrogen-Regulation of CXCL12 Chemokine Receptors, CXCR4 and CXCR7, Contributes to the Growth Effect of Estrogens in Breast Cancer Cells
- (2011) Antoine Boudot et al. PLoS One
- CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion
- (2011) Crystal Johnson-Holiday et al. World Journal of Surgical Oncology
- The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor
- (2010) Christine Bolitho et al. ENDOCRINE-RELATED CANCER
- Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma
- (2010) Bhawna Sharma et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Chemokine receptor CXCR7 regulates the invasion,angiogenesis and tumor growth of human hepatocellular carcinoma cells
- (2010) Ke Zheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell xenografts
- (2010) Kazuhito Izukuri et al. TRANSGENIC RESEARCH
- Chemokines and chemokine receptors: new insights into cancer-related inflammation
- (2010) Gwendal Lazennec et al. TRENDS IN MOLECULAR MEDICINE
- The inflammatory chemokines CCL2 and CCL5 in breast cancer
- (2008) Gali Soria et al. CANCER LETTERS
- Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain
- (2008) Cimona V. Hinton et al. CLINICAL & EXPERIMENTAL METASTASIS
- Functional Characterization of the ELR Motif in Piscine ELR+CXC-Like Chemokine
- (2008) Zhonghua Cai et al. MARINE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started